Japan Pharma Outlook 2020: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives
Japan Pharma Outlook 2020: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Japan Pharma Outlook 2020: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives Market.
View full press release